MORGAN SOLARI: Open Payments
NPI 1003562281 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,819 in 199 payments from 34 companies in 2025. Trend: 2023 $883 · 2024 $1,965 · 2025 $2,819
Food & beverage: $2,779Education: $40
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 39 | $404 |
| ABBVIE INC. | 24 | $341 |
| PFIZER INC. | 20 | $197 |
| Biogen, Inc. | 10 | $165 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $152 |
| Lilly USA, LLC | 16 | $144 |
| Teva Pharmaceuticals USA, Inc. | 21 | $144 |
| ACADIA Pharmaceuticals Inc | 13 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| HARMONY BIOSCIENCES LLC | 3 | $99 |
Products named: QULIPTA, Sunosi, NURTEC ODT, LUMRYZ, Symbravo, TYSABRI, KISUNLA, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
